Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date (Descending) Package Discontinuation Date Status
00002-5562-60 00002-5562 Selpercatinib RETEVMO 160.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, RET Oral April 10, 2024 In Use
00002-6082-60 00002-6082 Selpercatinib RETEVMO 80.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, RET Oral April 10, 2024 In Use
00002-6120-60 00002-6120 Selpercatinib RETEVMO 120.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, RET Oral April 10, 2024 In Use
68788-8626-01 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
68788-8626-03 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
68788-8626-06 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
68788-8626-09 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
00781-3528-10 00781-3528 Cyclophosphamide Cyclophosphamide 500.0 mg/5mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous April 8, 2024 In Use
00781-3529-10 00781-3529 Cyclophosphamide Cyclophosphamide 1000.0 mg/10mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous April 8, 2024 In Use
00781-3530-10 00781-3530 Cyclophosphamide Cyclophosphamide 2000.0 mg/20mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous April 8, 2024 In Use

Found 10,000 results in 2 milliseconds — Export these results